What Arvo does
Arvo uses AI and data integration to validate hospital billing and authorize procedures for Brazilian health insurance operators, aiming to cut fraud and inefficiency in healthcare payments. The company says its AI tools increase auditing and billing productivity by about 25% within six months and that it has processed more than R$130 billion in claims for over 65 operators, including Porto and Saúde Petrobras. Arvo was founded in 2022 by Fabrício Valadão and Rafael Tinoco, per Bloomberg Línea.
Arvo is a healthcare tool on Falcoscan. AI platform that validates hospital claims to stop healthcare payment fraud. Falcoscan rates Arvo with an Opportunity score of 84/100, a Saturation score of 11/100, and a Wrapper-risk score of 9/100. Market signal: rising. Arvo is founded in 2022, currently at Series_a stage. Pricing: Paid.